| Angel Antonio Ramos, APN | |
|
1051 W Sherman Ave, Vineland, NJ 08360-6931 | |
| (631) 534-7246 | |
| Not Available |
| Full Name | Angel Antonio Ramos |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 1051 W Sherman Ave, Vineland, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063059202 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 26NJ00996400 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulse Vascular Llc | 7618219361 | 22 |
News Archive
By 2020, the elderly are expected to comprise almost a quarter of Europe's total population. This changing demography is set to underpin a rise in the incidence of age-related orthopaedic problems
Recreational fishing in the U.S. is largely a personal hobby that scales up to a multibillion-dollar economic activity. More than 44 million people in the U.S. identify as recreational anglers making this hobby second only to jogging in terms of popular outdoor activities.
People's educational attainment influences their level of physical activity both during the week and on weekends, according to a study whose authors include two University of Kansas researchers.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 5 days ago
| Entity Name | Community Health Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700816816 PECOS PAC ID: 9335040419 Enrollment ID: O20040402000981 |
News Archive
By 2020, the elderly are expected to comprise almost a quarter of Europe's total population. This changing demography is set to underpin a rise in the incidence of age-related orthopaedic problems
Recreational fishing in the U.S. is largely a personal hobby that scales up to a multibillion-dollar economic activity. More than 44 million people in the U.S. identify as recreational anglers making this hobby second only to jogging in terms of popular outdoor activities.
People's educational attainment influences their level of physical activity both during the week and on weekends, according to a study whose authors include two University of Kansas researchers.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 5 days ago
| Entity Name | Pulse Vascular Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255899704 PECOS PAC ID: 7618219361 Enrollment ID: O20190429000797 |
News Archive
By 2020, the elderly are expected to comprise almost a quarter of Europe's total population. This changing demography is set to underpin a rise in the incidence of age-related orthopaedic problems
Recreational fishing in the U.S. is largely a personal hobby that scales up to a multibillion-dollar economic activity. More than 44 million people in the U.S. identify as recreational anglers making this hobby second only to jogging in terms of popular outdoor activities.
People's educational attainment influences their level of physical activity both during the week and on weekends, according to a study whose authors include two University of Kansas researchers.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 5 days ago
| Entity Name | Vascular Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053977801 PECOS PAC ID: 5395078000 Enrollment ID: O20190612002182 |
News Archive
By 2020, the elderly are expected to comprise almost a quarter of Europe's total population. This changing demography is set to underpin a rise in the incidence of age-related orthopaedic problems
Recreational fishing in the U.S. is largely a personal hobby that scales up to a multibillion-dollar economic activity. More than 44 million people in the U.S. identify as recreational anglers making this hobby second only to jogging in terms of popular outdoor activities.
People's educational attainment influences their level of physical activity both during the week and on weekends, according to a study whose authors include two University of Kansas researchers.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angel Antonio Ramos, APN 1051 W Sherman Ave, Vineland, NJ 08360-6931 Ph: (631) 534-7246 | Angel Antonio Ramos, APN 1051 W Sherman Ave, Vineland, NJ 08360-6931 Ph: (631) 534-7246 |
News Archive
By 2020, the elderly are expected to comprise almost a quarter of Europe's total population. This changing demography is set to underpin a rise in the incidence of age-related orthopaedic problems
Recreational fishing in the U.S. is largely a personal hobby that scales up to a multibillion-dollar economic activity. More than 44 million people in the U.S. identify as recreational anglers making this hobby second only to jogging in terms of popular outdoor activities.
People's educational attainment influences their level of physical activity both during the week and on weekends, according to a study whose authors include two University of Kansas researchers.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 5 days ago
Brian Hugh Shannon, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1138 E Chestnut Ave Ste 8b, Vineland, NJ 08360 Phone: 856-213-9733 Fax: 856-575-5080 | |
Erika Charlene Cruz, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1505 W Sherman Ave, Vineland, NJ 08360 Phone: 856-641-8000 | |
Anastasia Abena Amponsah, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 994 W Sherman Ave Bldg 2, Vineland, NJ 08360 Phone: 856-288-1281 | |
Maria Rosario Pagan, APNC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 602 W Sherman Ave, Vineland, NJ 08360 Phone: 856-691-1400 Fax: 856-691-7117 | |
Miss Suzett Simone Shaw, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2445 S Delsea Dr, Inspira Life Vineland, Vineland, NJ 08360 Phone: 856-334-1961 | |
Marcia Montanez Cathey, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3403 S Delsea Dr, Vineland, NJ 08360 Phone: 856-293-6974 |